Actavis shares should be bought at current levels, says RBC Capital RBC Capital believes that Actavis' stock does not yet reflect the company's positive outlook. The firm expects the company's earnings to surpass expectations going forward, and it thinks the company's EPS can grow at double digit percentage levels for the next several years. The firm keeps a $202 price target and Outperform rating on the stock.
News For ACT From The Last 14 Days
Check below for free stories on ACT the last two weeks.